Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial - Tashkin, D P; Roth, M D; Clements, P J (Lancet Respir Med, 2016)
et al.